PRADER-WILLI SYNDROME
Clinical trials for PRADER-WILLI SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRADER-WILLI SYNDROME trials appear
Sign up with your email to follow new studies for PRADER-WILLI SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug under observation for Prader-Willi syndrome
Disease control ENROLLING_BY_INVITATIONThis study watches 200 people with Prader-Willi syndrome who are taking VYKAT XR. Researchers will track side effects and how the drug affects their health. The goal is to learn more about the drug's safety and effects, not to cure the condition.
Matched conditions: PRADER-WILLI SYNDROME
Sponsor: Soleno Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New hope for rare hunger disorder: Long-Term drug trial underway
Disease control TerminatedThis study tests whether ARD-101 can safely reduce extreme hunger and food-related behaviors in people with Prader-Willi syndrome over 12 months. About 90 participants who completed a prior study will take the drug daily and visit the clinic regularly. The goal is to see if the d…
Matched conditions: PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 05:43 UTC
-
Promising drug targets severe hunger in rare genetic disorder
Disease control OngoingThis study tests a daily injection called setmelanotide in 18 people aged 6 to 65 with Prader-Willi syndrome, a condition causing severe obesity and constant hunger. The goal is to see if the drug safely reduces body weight and controls appetite over 52 weeks. Participants must h…
Matched conditions: PRADER-WILLI SYNDROME
Phase: PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New drug safety check for rare genetic disorder
Disease control ENROLLING_BY_INVITATIONThis study checks the safety of a drug called pitolisant in 150 people with Prader-Willi syndrome who have already taken it in a previous study. Researchers will track any side effects that happen during treatment and for 30 days after the last dose. The goal is to make sure the …
Matched conditions: PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Hope for rare hunger disorder: new drug trial targets Prader-Willi symptoms
Symptom relief TerminatedThis study tests whether the drug ARD-101 can reduce the intense, constant hunger (hyperphagia) seen in people with Prader-Willi syndrome. About 90 participants will take either ARD-101 or a placebo daily for 12 weeks. Researchers will track changes in hunger-related behaviors an…
Matched conditions: PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 06:01 UTC
-
New device could tame outbursts in rare genetic disorder
Symptom relief OngoingThis study tests a device that gently stimulates a nerve in the ear to see if it can reduce temper outbursts in people with Prader-Willi syndrome. About 102 participants aged 10 to 40 will use the device at home. The goal is to find a safe, tolerable, and effective way to manage …
Matched conditions: PRADER-WILLI SYNDROME
Phase: PHASE3 • Sponsor: Foundation for Prader-Willi Research • Aim: Symptom relief
Last updated May 26, 2026 05:45 UTC